Skip to content
Grochi · Neutral pet information from South Korea · English edition한국어
Grochi.English edition
Labels & regulation

Supplements vs. veterinary drugs in South Korean law

Translated from the Korean edition · Editorial draft, not professionally reviewed. This page is an English translation of the Korean edition as checked on 2026-11-22. If the two differ, the Korean edition is the reference. 한국어판 (Korean edition)

Supplements vs. veterinary drugs in South Korean law
Short answer

In South Korea, feed, veterinary quasi-drugs and veterinary drugs each have a different legal basis, supervising authority, route to market, labeling, place of sale and liability for violations. This article compares the 3 systems side by side, article by article.

Key takeaways

  • Feed is governed by the Control of Livestock and Fish Feed Act (사료관리법), with manufacturer registration and ingredient registration, while veterinary drugs are governed by the Pharmaceutical Affairs Act (약사법) and the Rules on the Handling of Veterinary Drugs, etc. (동물용 의약품등 취급규칙), with product approval or product notification. The 2 systems have different laws and different supervising authorities.
  • Under the Control of Livestock and Fish Feed Act, “supplementary feed” (보조사료) is a category set by public notice for substances added to feed to prevent deterioration of feed quality or to raise its usefulness; it does not mean the same thing as the English word “supplement.”
  • Article 61, paragraph 2 of the Pharmaceutical Affairs Act prohibits labeling and advertising that could be mistaken for a medical effect on something that is not a medicine, and Article 93 of the same Act provides for imprisonment of up to 5 years or a fine of up to KRW 50,000,000 for violations.
  • The principle in Article 44, paragraph 1 of the Pharmaceutical Affairs Act is that veterinary drugs cannot be sold by anyone other than a pharmacy opener, and Article 85, paragraph 4 provides a special rule for animal hospital openers. Prescription veterinary drugs cannot be sold without a veterinarian's prescription.
  • You cannot tell from the name alone which system a supplement on the market is actually managed under, so check the product package to see whether it carries a feed ingredient-registration label or a veterinary drug or veterinary quasi-drug label.

The conclusion first: 3 tracks with different laws and authorities, even when the names look alike

To a pet owner, supplements, health products and medicines given to a pet look like similar kinds of things, but in Korean law they sit under different systems. Feed falls under the Control of Livestock and Fish Feed Act (사료관리법), while veterinary drugs and veterinary quasi-drugs are based mainly on the Pharmaceutical Affairs Act (약사법) and the Rules on the Handling of Veterinary Drugs, etc. (동물용 의약품등 취급규칙) (hereafter the Handling Rules). Exactly which items count as veterinary quasi-drugs is covered by the Regulation on the Scope and Designation of Veterinary Quasi-drugs (동물용의약외품의 범위 및 지정 등에 관한 규정), which is set by the head of the Animal and Plant Quarantine Agency (APQA).

The 3 systems differ in 8 respects: what counts under the legal definition, who manages it, what it must go through before reaching the market, what the package must state, what effects may be claimed, where it may be sold, where problems are reported, and what happens on a violation. This article places those 8 items side by side, within the range confirmed by opening the original legal texts.

How to work out whether a single product in front of you is feed or a medicine is covered in an earlier Grochi article, “Is a pet supplement feed or a veterinary drug?” That article has a different role from this one. This article does not judge individual products; it explains, centered on the articles of law, how the 3 systems themselves are divided in law.

This article does not cover which ingredients are effective, whether your own pet needs one, or how much to give. Those are matters to discuss with a veterinarian.

Legal definitions: where does feed end and medicine begin?

Article 2, item 1 of the Control of Livestock and Fish Feed Act defines feed as something that provides nutrition to livestock or to other animals announced by the Minister of Agriculture, Food and Rural Affairs, or that is needed for their health maintenance or growth, meaning single-ingredient feed, formula feed and supplementary feed. A proviso then follows excluding anything ingested as a veterinary medicine. Article 2, item 4 of the same Act defines supplementary feed as something added to feed to prevent deterioration of feed quality or to raise the usefulness of feed, as announced by the Minister of Agriculture, Food and Rural Affairs. In Korean law, supplementary feed in this sense refers to an additive put into feed, so it does not mean the same thing as the English word “supplement,” that is, a nutritional supplement.

Article 2, item 4 of the Pharmaceutical Affairs Act defines a medicine in 3 ways: an article listed in the Korean Pharmacopoeia that is not a quasi-drug; an article used for the purpose of diagnosing, treating, alleviating, managing or preventing disease in people or animals, other than an instrument, machine or device; and an article used for the purpose of exerting a pharmacological effect on the structure and function of people or animals, other than an instrument, machine or device. It differs from the definition of feed in that the definition turns on the purpose of use. Feed is defined by nutrition and by health maintenance and growth, while a medicine is defined by the purpose of responding to disease or exerting a pharmacological effect.

Article 2, paragraph 1, item 1 of the Handling Rules says that a veterinary drug is a medicine intended for use on animals only, and notes that it includes medicines for pets. Item 3 of the same paragraph divides veterinary quasi-drugs into 2 types. Sub-item (a) covers pet preparations such as mouth fresheners, cleaners and deodorants, disinfectants for animal disease prevention, pest control agents, and vitamin preparations as nutritional supplements, that is, products whose action on animals is slight or not direct and that are not instruments or machines, and anything similar. Sub-item (b) covers textile and rubber products used to treat, alleviate, manage or prevent animal disease, and anything similar. Both are limited to what the head of the APQA or the Commissioner of the National Fishery Products Quality Management Service sets by public notice.

Where the 3 definitions overlap is sorted out by Article 2, paragraph 2 of the Handling Rules. It provides that a feed additive that is of an ingredient not needing to be managed as a veterinary drug or veterinary quasi-drug, or that falls short of the required content, and that is managed as feed under the Control of Livestock and Fish Feed Act, is not regarded as a veterinary drug or veterinary quasi-drug. Here, Article 2, paragraph 1, item 6 defines a feed additive as a veterinary drug or veterinary quasi-drug that adds vitamins, antibacterials, enzymes, probiotics, amino acids, trace minerals and the like to feed and is used for purposes such as preventing disease, replenishing deficiencies, improving feed efficiency and promoting growth. This means that the same ingredient can be managed on the medicine side or on the feed side depending on the type of ingredient and its content.

Supervising authorities and the route to market

Feed comes under the Minister of Agriculture, Food and Rural Affairs, and much of the practical work is done by city and provincial governors. Article 8, paragraph 1 of the Control of Livestock and Fish Feed Act provides that a person who wants to run a manufacturing business must register with the city or provincial governor, and Article 12, paragraph 1 requires a manufacturer or importer to carry out ingredient registration, registering the type, ingredients and ingredient amounts of the feed to be manufactured or imported with the city or provincial governor. The governor checks whether the application conforms to the feed process standards and, if it does, issues an ingredient registration certificate. Under Article 14, paragraph 1, item 5, feed manufactured or imported without ingredient registration may not be manufactured, imported or sold. Article 12 of the Enforcement Rule of the Control of Livestock and Fish Feed Act requires that the ingredient registration application be accompanied by documents stating the names of the raw materials used, a description of the manufacturing process, and so on. No procedure that reviews safety and efficacy the way a medicine is reviewed was found in these articles.

For veterinary drugs and veterinary quasi-drugs, the provisions of the Pharmaceutical Affairs Act are applied with modifications for animal use. Article 85, paragraph 1 of the Pharmaceutical Affairs Act provides that, for medicines and similar items intended for animal use only, matters under the jurisdiction of the Minister of Health and Welfare or the Minister of Food and Drug Safety fall under the jurisdiction of the Minister of Agriculture, Food and Rural Affairs or the Minister of Oceans and Fisheries. Article 2-2, paragraph 1 of the Handling Rules places tasks relating to the manufacture, import and sale of veterinary drugs and veterinary quasi-drugs for pets (excluding ornamental fish) under the jurisdiction of the head of the APQA.

Article 31, paragraph 2 of the Pharmaceutical Affairs Act provides that, to sell a medicine made by a medicine manufacturer, the manufacturer must obtain manufacturing and sales product approval or file a product notification for each product, and paragraph 4 of the same Article provides that a person who wants to manufacture quasi-drugs as a business must file a manufacturing business notification and obtain product approval or file a product notification for each product. Article 5, paragraph 1 of the Handling Rules lists as requiring product approval veterinary drugs and the veterinary quasi-drugs that fall under Article 2, paragraph 1, item 3, sub-item (a) (excluding some products set by public notice). Paragraph 2 of the same Article places veterinary quasi-drugs under item 3, sub-item (b) and the like within the scope of product notification. Paragraph 3 of the same Article provides that an approval application must be accompanied by documents on efficacy and effects, directions and dose, precautions and test methods, and documents needed for the review of safety and efficacy. Paragraph 5 of the same Article also requires applications for approval of veterinary drugs to be divided into those for animals, for beekeeping, for sericulture, for fisheries and for pets, and requires prescription veterinary drugs to be applied for separately.

To sum up, feed goes through a registration-centered procedure of business registration and ingredient registration, while a veterinary drug goes through product approval, in which safety and efficacy are reviewed. Among veterinary quasi-drugs, the sub-item (a) products, which include vitamin preparations as nutritional supplements, are also listed as subject to product approval under Article 5, paragraph 1 of the Handling Rules.

What must be labeled, and the range of effects that may be claimed

Article 13, paragraph 1 of the Control of Livestock and Fish Feed Act provides that a manufacturer, importer or seller who wants to sell feed must state on the container or package the registered ingredient items, the sell-by date, and other precautions for use and other matters set by ordinance of the Ministry of Agriculture, Food and Rural Affairs. Article 14 of the Enforcement Rule of the Control of Livestock and Fish Feed Act refers the detailed items to Appendix Table 4, and I could not open the text of Appendix Table 4 directly this time. Paragraph 2 of Article 13 prohibits labeling that is false or exaggerated.

For veterinary drugs and veterinary quasi-drugs, Article 42 of the Handling Rules applies. On the container or package and in the accompanying document, a veterinary drug must be marked “veterinary drug” and a veterinary quasi-drug “veterinary quasi-drug,” in a way distinguishable from other text. The same paragraph also contains a provision to the effect that a veterinary drug for pets is marked as a pet veterinary drug and a prescription veterinary drug is separately marked as prescription-only. Paragraph 2 of the same Article requires the storage method, withdrawal period, contraindications, precautions and side effects set at the time of product approval, together with the product category and the efficacy and effects, to be stated. What I confirmed in the feed labeling provisions are the ingredient-registration items, the sell-by date and precautions; I could not confirm an item for stating approved efficacy and effects the way a medicine does.

The range of effects that can be claimed also differs. Article 68, paragraph 5 of the Pharmaceutical Affairs Act provides that no one may advertise the name, manufacturing method, efficacy or performance of a medicine or similar item until after obtaining approval or change approval, or filing a notification or change notification, under Article 31. That is, medicines and quasi-drugs may claim effects within the range that has gone through approval or notification. By contrast, Article 61, paragraph 2 of the Pharmaceutical Affairs Act provides that no one may put on the container, package or accompanying document of something that is not a medicine a label that could be mistaken for having a medical efficacy or effect, or run an advertisement with such content, nor sell, or store or display for sale, something labeled or advertised that way. Read together with the fact that the definition in the Control of Livestock and Fish Feed Act does not include the purpose of diagnosing or treating disease, this means that an unapproved product claiming an effect on disease is out of step with the system.

In addition, Article 68, paragraph 1 of the Pharmaceutical Affairs Act prohibits false and exaggerated advertising of the efficacy or performance of medicines and similar items, and paragraph 2 prohibits the use of articles that could be mistaken as a guarantee of efficacy by a veterinarian or similar person. Paragraph 3 also prohibits advertising that uses suggestive methods such as articles, photographs and designs that hint at efficacy or performance.

The 3 systems side by side (within the range confirmed in the legal texts; cells that could not be confirmed are marked as such)
Item comparedFeed (including supplementary feed)Veterinary quasi-drugVeterinary drug
Legal basisControl of Livestock and Fish Feed ActPharmaceutical Affairs Act, Handling Rules, Regulation on the Scope and Designation of Veterinary Quasi-drugsPharmaceutical Affairs Act, Handling Rules
Defining provisionsControl of Livestock and Fish Feed Act Article 2, items 1 and 4Handling Rules Article 2, paragraph 1, item 3 (sub-items (a) and (b))Handling Rules Article 2, paragraph 1, item 1; Pharmaceutical Affairs Act Article 2, item 4
Supervising authorityMinister of Agriculture, Food and Rural Affairs, city and provincial governors (Articles 8 and 12)Pet products are under the head of the APQA (Handling Rules Article 2-2, paragraph 1)Pet products are under the head of the APQA (Handling Rules Article 2-2, paragraph 1)
Route to marketManufacturing business registration (Article 8), ingredient registration (Article 12)Sub-item (a) by product approval, sub-item (b) by product notification (Handling Rules Article 5)Product approval in principle, some by product notification (Handling Rules Article 5, Pharmaceutical Affairs Act Article 31)
LabelingIngredient-registration items, sell-by date, precautions, etc. (Article 13; details in Enforcement Rule Appendix Table 4, text not confirmed)Product category label, efficacy and effects, precautions, etc. (Handling Rules Article 42)Product category label, withdrawal period, contraindications, side effects, efficacy and effects, etc. (Handling Rules Article 42)
Effects that may be claimedLabeling that could be mistaken for a medical effect is prohibited (Pharmaceutical Affairs Act Article 61, paragraph 2); false or exaggerated labeling is prohibited (Control of Livestock and Fish Feed Act Article 13, paragraph 2)May be advertised after approval or notification (Pharmaceutical Affairs Act Article 68, paragraph 5)May be advertised after approval or notification; advertising of prescription-only medicines is prohibited (Pharmaceutical Affairs Act Article 68, paragraphs 5 and 6)
Place of saleSellers bear labeling and prohibition duties (Articles 13 and 14); no provision restricting places of sale was confirmedPharmaceutical Affairs Act Article 44 concerns the sale of medicines; the place of sale of veterinary quasi-drugs was not confirmedPharmacy openers (Pharmaceutical Affairs Act Article 44, paragraph 1), animal hospital openers (Article 85, paragraph 4), wholesalers, etc. (Pharmaceutical Affairs Act Article 44, paragraph 2, item 2; Article 85, paragraph 12)

Where is it sold, and where do I report a problem?

The places where veterinary drugs are sold are stated fairly clearly in the Pharmaceutical Affairs Act. Article 44, paragraph 1 of the Pharmaceutical Affairs Act provides that no one other than a pharmacy opener may sell a medicine or acquire it for sale, with exceptions such as a holder of product approval for a medicine or an importer selling to a person who may manufacture or sell the medicine. Article 85, paragraph 4 provides that an animal hospital opener under the Veterinarians Act (수의사법) may, notwithstanding Article 44, sell veterinary drugs to animal keepers, and Article 85, paragraph 12 provides that a person licensed as a veterinary drug wholesaler may sell to animal keepers as prescribed by ordinance of the Ministry of Agriculture, Food and Rural Affairs.

Article 2, paragraph 1, item 10 of the Handling Rules defines a prescription veterinary drug as a veterinary drug that cannot be sold without a prescription from a veterinarian or an aquatic disease management specialist. Article 85, paragraph 6 of the Pharmaceutical Affairs Act prevents a person licensed as a veterinary drug wholesaler from selling, without a veterinarian's prescription, veterinary drugs announced by the Minister of Agriculture, Food and Rural Affairs, such as drugs that may harm the health of people and animals through misuse or abuse and drugs requiring a veterinarian's specialized knowledge (with sales among animal hospital openers, pharmacy openers and wholesalers as an exception), and paragraph 7 provides that a pharmacy opener may sell such drugs without a prescription, except for injectable antibiotic preparations and injectable biological preparations. This article is not guidance on which drug to buy and where; it only explains the fact that the sales system is divided this way.

As for where feed is sold, I could not confirm any provision in the Control of Livestock and Fish Feed Act restricting places of sale. What I did confirm is that a seller also bears labeling duties (Article 13), and that feed manufactured or imported without ingredient registration, or feed past its sell-by date, may not be sold (Article 14, paragraphs 1 and 3). The place of sale of veterinary quasi-drugs also could not be confirmed in the provisions opened this time.

The route for reporting side effects or quality problems also differs by system. Article 14, paragraph 1, item 4 and paragraph 2 of the Handling Rules require a veterinary drug manufacturer, on learning new information relating to the safety and efficacy of an approved product (including cases of side effects), to take safety measures and to report the matter without delay to the head of the APQA and others. Article 26-2, paragraph 1 of the Handling Rules requires an animal pharmacy or animal hospital opener, and a seller, to stop selling or handling a product immediately if it is suspected of being subject to recall, and to notify the manufacturer and others. Article 68-8 of the Pharmaceutical Affairs Act also requires manufacturers, holders of product approval, importers and wholesalers to report adverse events when they learn of them, and under Article 85, paragraph 1 of the same Act the authority is read as changed for animal use. I could not confirm, on the front page of the APQA website opened this time, a desk where an owner can directly file a side-effect report. That front page did have a menu for reporting illegal online sales of veterinary drugs and a shortcut to electronic civil petitions for veterinary drugs.

For feed, under Article 21 of the Control of Livestock and Fish Feed Act the Minister of Agriculture, Food and Rural Affairs or the city or provincial governor may carry out feed inspections, and under Article 24 may order measures such as recall and disposal when, for example, the ingredients differ from the registered items by more than the standard allows.

What happens on a violation?

The penalties in the Control of Livestock and Fish Feed Act fall into 2 tiers. Article 33 provides imprisonment of up to 3 years or a fine of up to KRW 30,000,000 for a person who manufactured, imported or sold feed in violation of Article 14, paragraph 1, that is, a person who handled feed containing harmful substances at or above the permitted standard, among others. Article 34 lists, as subject to imprisonment of up to 1 year or a fine of up to KRW 10,000,000, a person who ran a manufacturing business without manufacturing business registration, a person who manufactured or imported feed without ingredient registration, a person who sold feed without the required labeling, a person who labeled falsely or in an exaggerated way, and a person who sold, or kept or displayed for sale, feed past its sell-by date.

The penalties in the Pharmaceutical Affairs Act are heavier. Article 93, paragraph 1 provides imprisonment of up to 5 years or a fine of up to KRW 50,000,000 for a person who failed to obtain approval or file a notification in violation of Article 31, paragraphs 1 to 4 (item 4), a person who violated Article 44, paragraph 1 (item 7), and a person who violated Article 61 (item 10), and states that imprisonment and a fine may be imposed together. Article 95, paragraph 1, item 10 provides imprisonment of up to 1 year or a fine of up to KRW 10,000,000 for a person who violated the prohibition on exaggerated advertising and the like in Article 68. Under Article 85, paragraph 1 of the Pharmaceutical Affairs Act the minister with jurisdiction is read as changed for animal use, but the penalty provisions themselves are in that Act.

When a product that is not a medicine claims a medical effect, it violates Article 61, paragraph 2 of the Pharmaceutical Affairs Act, and the fact that a violation of Article 61 falls under Article 93, paragraph 1, item 10 is a link between the provisions opened this time. However, how any provision applies in an individual case is not judged in this article.

There are also administrative sanctions. Article 12, paragraph 3 of the Control of Livestock and Fish Feed Act provides that the city or provincial governor cancels the ingredient registration where, for example, it was made by false or other improper means, and feed becomes subject to a recall or disposal order under Article 24. For veterinary drugs and similar items, Article 26-2 of the Handling Rules has risk assessed by grade. Article 39, paragraph 1 of the Pharmaceutical Affairs Act requires a person who learns that a medicine or similar item violates Article 61 or the like and has a problem with safety or efficacy to recall it without delay or take the measures needed for recall, and Article 94, paragraph 1, item 4-2 makes a person who fails to do so subject to imprisonment of up to 3 years or a fine of up to KRW 30,000,000.

How is it different abroad? The U.S. FDA sorts by intended use

The U.S. Food and Drug Administration (FDA) page on pet food regulation explains that whether a product is a drug is decided by its intended use. According to that page, if the intended use is to treat or prevent disease, the product is a drug. If the purpose is to affect the structure or function of the body and the effect does not come primarily from nutrition, taste or aroma, it is also a drug. Examples the FDA gives include a cat food intended to acidify the urine and a dog food intended to improve joint function in dogs with arthritis.

The same page says that most complete foods intended to treat or prevent disease are not approved animal drugs, and explains that the FDA regards such unapproved products as unapproved animal drugs. It also says that in most cases the federal Food, Drug, and Cosmetic Act requires FDA approval before an animal drug is sold, whereas animal food can be sold without the same kind of premarket approval unless it is a food additive. On animal supplements, it states that the laws that apply to human dietary supplements do not apply to animal products, and that animal supplements are not a separate category but are regulated as animal food or animal drugs depending on their ingredients and intended use.

The FDA page on the animal drug approval process explains that approval of a drug reviews, all together, safety in the target animal, effectiveness, manufacturing methods and quality, and labeling. Approval means that the drug has been judged safe and effective when used as labeled and that its strength and quality are maintained from batch to batch.

There is a point in common with Korea. In both countries, the line between feed and medicine rests on definition and purpose of use, not on the name of the product. There are also differences. Korea sets out in its articles 3 tracks, feed, veterinary quasi-drugs and veterinary drugs, and separately defines the intermediate category of quasi-drugs, whereas the FDA page describes 2 tracks, animal food and animal drugs. This difference only shows that the 2 countries' legal terms and responsible authorities differ, and the standards of one country cannot be applied as they are to products of another. In the FDA pages opened this time, I could not confirm a category corresponding to Korea's veterinary quasi-drugs.

Common misunderstandings and what to check

The first misunderstanding is the idea that a supplement is an independent third legal category between feed and medicine. In the provisions opened this time, “supplement” was not confirmed as a term of the system. Only the definition of feed, the definition of veterinary drugs and the definition of veterinary quasi-drugs (which includes vitamin preparations as nutritional supplements) are confirmed. So the name “supplement” alone does not tell you which system a product is under. I could not confirm from the original texts of the laws and public notices which feed category (single-ingredient feed, formula feed or supplementary feed) a supplement on the market is actually registered under, so the registration category should be checked on each product's package.

The second misunderstanding is the idea that something carrying the words “supplementary feed” is a product that supports health. As seen above, supplementary feed in Article 2, item 4 of the Control of Livestock and Fish Feed Act is a category of substances added to feed to prevent deterioration of feed quality or to raise its usefulness.

The third misunderstanding is the idea that an approved drug can be bought anywhere. Reading Article 44, paragraph 1 and Article 85 of the Pharmaceutical Affairs Act, places of sale are divided into pharmacies, animal hospitals, wholesalers and so on, and prescription veterinary drugs require a prescription.

The points an owner can check on a product package are as follows.

  • Look for a label relating to feed ingredient registration, and for a category label saying veterinary drug or veterinary quasi-drug. Article 42 of the Handling Rules requires this category to be marked on veterinary drugs and veterinary quasi-drugs.
  • If there is wording that names a disease or speaks of treatment or prevention, first check which system the product belongs to. Article 61, paragraph 2 of the Pharmaceutical Affairs Act prohibits a non-medicine from carrying a label that could be mistaken for a medical effect.
  • If your pet is already taking a medicine, tell your veterinarian before giving a new product.
  • If the classification is unclear, ask the manufacturer for the registration category, and for a suspicious online sale, check the menu for reporting illegal online sales of veterinary drugs on the APQA website.

For the amount to give and how to give it, follow the product instructions and your veterinarian's guidance.

When to see a veterinarian

An explanation of the system cannot answer whether a medicine is needed or a supplement is needed. When your pet looks unwell or different from usual, when it is already taking a hospital-prescribed medicine and you want to add a new product, or when changes such as vomiting, diarrhea, reduced appetite or lethargy appear after giving it, contact an animal hospital before arguing over product classification. Bringing a record of the product package and the amount given helps the consultation.

If there are urgent signs such as labored breathing, collapse or seizures, go straight to an animal hospital that can provide emergency care. In that case, which product belongs to which system does not matter; just bring the package of the product that was given.

Do not think of using a human medicine or a livestock medicine on a pet as a substitute either. Even medicines approved for animals have methods of use set by species and by whether a prescription is required, and actual administration must follow the guidance of a veterinarian or the product instructions.

If you suspect that a product's labeling and classification do not match, for feed you can inquire with the manufacturer named on the product package and with the local government in charge, and for illegal online sales of veterinary drugs with the reporting menu on the APQA website. Laws are amended, so check the current text of the articles before buying or giving a product.

Frequently asked questions

Q In Korean law, is a supplement feed or a medicine?

An independent legal classification called “supplement” was not confirmed in the provisions opened this time. Each product is managed as one of feed under the Control of Livestock and Fish Feed Act, a veterinary quasi-drug, or a veterinary drug. Which one an individual product falls under should be checked from the labeling on its package.

Q Does “supplementary feed” mean a health supplement product?

No. Article 2, item 4 of the Control of Livestock and Fish Feed Act defines supplementary feed as something added to feed to prevent deterioration of feed quality or to raise the usefulness of feed, as announced by the Minister of Agriculture, Food and Rural Affairs. It does not mean the same thing as the English word “supplement.”

Q What kinds of articles are veterinary quasi-drugs?

Article 2, paragraph 1, item 3 of the Handling Rules lists, in sub-item (a), pet preparations, disinfectants for animal disease prevention, pest control agents and vitamin preparations as nutritional supplements, whose action on animals is slight or not direct, and, in sub-item (b), textile and rubber products for treating, alleviating, managing or preventing animal disease. The specific scope is set by public notice of the head of the APQA.

Q May a product registered as feed claim to prevent disease?

Article 61, paragraph 2 of the Pharmaceutical Affairs Act prohibits labeling and advertising that could be mistaken for a medical efficacy or effect on something that is not a medicine. Article 13, paragraph 2 of the Control of Livestock and Fish Feed Act also prohibits false or exaggerated labeling. If you see such wording, it is advisable to ask the manufacturer about the product's classification.

Q Where can veterinary drugs be sold?

Article 44, paragraph 1 of the Pharmaceutical Affairs Act provides that no one other than a pharmacy opener may sell a medicine, and Article 85, paragraph 4 provides that an animal hospital opener may sell veterinary drugs to animal keepers. Prescription veterinary drugs cannot be sold without a veterinarian's prescription. This article does not encourage buying.

Q Where do I report it if a product causes a problem?

Contact an animal hospital first. Under the system, Article 14, paragraph 2 of the Handling Rules and Article 68-8 of the Pharmaceutical Affairs Act place a duty on manufacturers and others to report side-effect information. I could not confirm, on the front page of the APQA website opened this time, a side-effect desk that owners can file with directly.

Q What penalties apply for violations?

Article 33 of the Control of Livestock and Fish Feed Act provides imprisonment of up to 3 years or a fine of up to KRW 30,000,000, and Article 34 provides imprisonment of up to 1 year or a fine of up to KRW 10,000,000 for violations such as those concerning ingredient registration or labeling. Article 93, paragraph 1 of the Pharmaceutical Affairs Act provides imprisonment of up to 5 years or a fine of up to KRW 50,000,000 for a person who manufactured or sold without approval or notification and a person who violated Article 44 or 61.

Limits and scope of this guide

This article is an editorial draft and has not been through specialist review by a veterinarian or pharmacist. It compares only the framework of the systems on the basis of the articles of Korean law, and does not judge which system an individual product belongs to. I could not confirm Appendix Table 4 of the Enforcement Rule of the Control of Livestock and Fish Feed Act, the appendix tables of the Standards and Specifications for Feeds (사료 등의 기준 및 규격), the text of the appendix table of the veterinary quasi-drug scope regulation, the provisions on places of sale for feed and for veterinary quasi-drugs, a side-effect reporting desk that owners can file with directly, or actual examples of how supplements on the market are registered by feed category. The effects and necessity of nutritional ingredients and the amount to give are not covered. Laws can be amended, so check the current text of the articles and your veterinarian's guidance before buying or giving a product.

Translated from the Korean edition · Editorial draft, not professionally reviewed. The Korean edition is an explainer newly written from public sources; it is not a full translation of those sources. Veterinary expert review has not been completed. For decisions about your pet's health, talk to a veterinarian who knows your pet.

Sources and check dates

  1. Pharmaceutical Affairs Act, Articles 2, 31, 44, 61, 68, 68-8, 85 and 93 to 95 (약사법) ↗

    Used as the basis for the definitions of medicines and quasi-drugs, product approval and notification, places of sale, the prohibition on labels mistaken for a medical effect, the special rules for animal use, and the penalty provisions.

  2. Rules on the Handling of Veterinary Drugs, etc., Articles 2, 2-2, 5, 14, 26-2 and 42 (동물용 의약품등 취급규칙) ↗

    Used as the basis for the definitions of veterinary drugs, veterinary quasi-drugs and feed additives, the supervising authority, the products subject to approval or notification, labeling items, and the duties to report side effects and to notify of recalls.

  3. Regulation on the Scope and Designation of Veterinary Quasi-drugs, Articles 1 to 3 (동물용의약외품의 범위 및 지정 등에 관한 규정) ↗

    Used as the basis for the point that the scope of quasi-drugs is set in an appendix table and that the head of the APQA reviews whether a product falls within it. The text of the appendix table could not be opened and confirmed.

  4. Control of Livestock and Fish Feed Act, Articles 2, 8, 12, 14, 21, 24, 33 and 34 (사료관리법) ↗

    Used as the basis for the definitions of feed and supplementary feed, manufacturing business registration and ingredient registration, labeling duties, feed that may not be sold, inspections and recall orders, and the penalties.

  5. Enforcement Rule of the Control of Livestock and Fish Feed Act, Articles 12 and 14 (사료관리법 시행규칙) ↗

    Used as the basis for the point that the documents for an ingredient registration application and the labeling items are set in Appendix Table 4. The text of Appendix Table 4 could not be opened and confirmed.

  6. Website of the Animal and Plant Quarantine Agency (농림축산검역본부 누리집) ↗

    Used to confirm the menu for reporting illegal online sales of veterinary drugs and the shortcut to electronic civil petitions for veterinary drugs on the front page; a side-effect reporting desk could not be confirmed.

  7. FDA's Regulation of Pet Food ↗

    Used as the basis for the criterion of sorting drug from food by intended use, the explanation that animal supplements are not a separate category, and the difference in premarket approval.

  8. From an Idea to the Marketplace: The Journey of an Animal Drug through the Approval Process ↗

    Used as the basis for the explanation that animal drug approval reviews safety, effectiveness, manufacturing and labeling.

Korean edition checked · translated · each source may have a different check date. No paid partnerships.

This guide relies on 7 Korean laws or notices. Current effective dates and upcoming amendments are listed on Korean law check status. This is not legal advice.